Studer Family Children's Hospital at Ascension Sacred Heart in Pensacola, Fla., is opening a pediatric oncology and hematology center May 10, the Pensacola News Journal reports.
Uncategorized
How pandemic has advanced heart failure treatment: Baylor's chief of transplant cardiology weighs in
Shelley Hall, MD, chief of transplant cardiology and advanced heart failure at Baylor University Medical Center in Dallas, spoke about emerging innovations in congestive heart failure treatment during a recent episode of the Becker's Healthcare cardiology podcast.
May/June 2021 Issue of Becker’s Clinical Leadership & Infection Control ON THE COVER Why demand for physician leaders is growing As a practicing OB-GYN in the 1980s, Lawrence Antonucci, MD, didn’t necessarily aspire to become CEO of a health system.…
Patients living in disadvantaged neighborhoods are more likely to die within five years of a heart attack compared to those living in wealthier neighborhoods, according to research set to be presented May 15-17 during the American College of Cardiology's 70th…
These five oncology leaders joined new practices or received new appointments over the last few months.
Advertisement
In an era of infinite challenges and finite resources, health systems must employ a rigorous approach to strategic and facility planning. This is particularly true for oncology, where the pace of change and innovation is unprecedented.
Three cancer centers in the Southeast will work to develop a program that advances veterans' access to lung cancer clinical trials, according to a May 3 announcement.
Nashville, Tenn.-based Ascension Saint Thomas Heart will train the next generation of cardiologists with the launch of a cardiology fellowship program, according to a May 3 announcement shared with Becker's.
As the COVID-19 pandemic eases in the U.S., so has the fear of visiting a clinical setting. With that has come a wave of progressing cancer diagnoses that slipped through the cracks amid earlier stages of the pandemic, ProPublica reported…
The National Cancer Institute has granted $3 million to researchers from UPMC Hillman Cancer Center in Pittsburgh and Indiana University Melvin and Bren Simon Comprehensive Cancer Center in Indianapolis to study cognitive dysfunction after chemotherapy.